Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin vs Botox for Spasticity in Pediatric Cerebral Palsy
NCT02188277Phase 2Completed
- Sponsor
- Merz
- Start
- Jul 2014
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of incobotulinumtoxinA in cerebral palsy (CP), sponsored by Merz. Started Jul 2014; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02188277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188277.